Prevalence and Localization of Hibernating Myocardium Among Patients with Left Ventricular Dysfunction

Author(s): Emine Acar*, Ayşegül Aksu, Gökmen Akkaya, Gamze Çapa Kaya.

Journal Name: Current Medical Imaging
Formerly: Current Medical Imaging Reviews

Volume 15 , Issue 9 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Objective: This study evaluated how much of the myocardium was hibernating in patients with left ventricle dysfunction and/or comorbidities who planned to undergo either surgical or interventional revascularization. Furthermore, this study also identified which irrigation areas of the coronary arteries presented more scar and hibernating tissue.

Methods: At rest, Tc-99m MIBI SPECT and cardiac F-18 FDG PET/CT images collected between March 2009 and September 2016 from 65 patients (55 men, 10 women, mean age 64±12) were retrospectively analyzed in order to evaluate myocardial viability. The areas with perfusion defects that were considered metabolic were accepted as hibernating myocardium, whereas areas with perfusion defects that were considered non-metabolic were accepted as scar tissue.

Results: Perfusion defects were observed in 26% of myocardium, on average 48% were associated with hibernation whereas other 52% were scar tissue. In the remaining Tc-99m MIBI images, perfusion defects were observed in the following areas in the left anterior descending artery (LAD; 31%), in the right coronary artery (RCA; 23%) and in the Left Circumflex Artery (LCx; 19%) irrigation areas. Hibernation areas were localized within the LAD (46%), LCx (54%), and RCA (64%) irrigation areas. Scar tissue was also localized within the LAD (54%), LCx (46%), and RCA (36%) irrigation areas.

Conclusion: Perfusion defects are thought to be the result of half hibernating tissue and half scar tissue. The majority of perfusion defects was observed in the LAD irrigation area, whereas hibernation was most often observed in the RCA irrigation area. The scar tissue development was more common in the LAD irrigation zone.

Keywords: FDG, myocardium, hibernation, scar, viability, perfusion defects.

[1]
Allman KC. Noninvasive assessment myocardial viability: current status and future directions. J Nucl Cardiol 2013; 20(4): 618-37.
[http://dx.doi.org/ 10.1007/s12350-013-9737-8] [PMID: 23771636]
[2]
Anagnostopoulos C, Georgakopoulos A, Pianou N, Nekolla SG. Assessment of myocardial perfusion and viability by positron emission tomography. Int J Cardiol 2013; 167(5): 1737-49.
[http://dx.doi.org/10.1016/j.ijcard.2012.12.009] [PMID: 23313467]
[3]
Cortigiani L, Bigi R, Sicari R. Is viability still viable after the STICH trial? Eur Heart J Cardiovasc Imaging 2012; 13(3): 219-6.
[http://dx.doi.org/10.1093/ejechocard/jer237] [PMID: 22080451]
[4]
AlJaroudi WA, Hage FG. Review of cardiovascular imaging in the journal of nuclear cardiology in 2015. Part 1 of 2: Plaque imaging, positron emission tomography, computed tomography, and magnetic resonance. J Nucl Cardiol 2016; 23(1): 122-30.
[http://dx.doi.org/10.1007/s12350-015-0319-9] [PMID: 26542991]
[5]
Saha GB, MacIntyre WJ, Brunken RC, et al. Present assessment of myocardial viability by nuclear imagingSemin Nucl Med 1996; 26(4): 315-5.
[http://dx.doi.org/10.1016/S0001-2998(96)80007-9] [PMID: 8916320]
[6]
Al Moudi M, Sun ZH. Diagnostic value of (18)F-FDG PET in the assessment of myocardial viability in coronary artery disease: A comparative study with (99m)Tc SPECT and echocardiography. J Geriatr Cardiol 2014; 11(3): 229-36.
[PMID: 25278972]
[7]
Al-Mohammad A, Norton MY, Welch AE, Walton S. Characterization of viability, scarring and hibernation of the myocardium supplied by epicardial coronary arteries with low flow grades Nucl Med Commun 2017; 38(8): 657-.
[http://dx.doi.org/10.1097/MNM.0000000000000683] [PMID: 28700405]
[8]
Beanlands RS, Nichol G, Huszti E, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007; 50(20): 2002-12.
[http://dx.doi.org/10.1016/j.jacc.2007.09.006] [PMID: 17996568]
[9]
Bax JJ, Patton JA, Poldermans D, Elhendy A, Sandler MP. 18- Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications. Semin Nucl Med 2000; 30(4): 281-98.
[http://dx.doi.org/10.1053/snuc.2000.9543] [PMID: 11105929]
[10]
Hansen AK, Gejl M, Bouchelouche K, Tolbod LP, Gormsen LC. Reverse mismatch pattern in cardiac 18F-FDG viability PET/CT Is not associated with poor outcome of revascularization: A retrospective outcome study of 91 patients with heart failure. Clin Nucl Med 2016; 41(10): e428-35.
[http://dx.doi.org/10.1097/RLU.0000000000001312] [PMID: 27488429]
[11]
Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36(11): 2138-47.
[PMID: 7472611]
[12]
Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes Curr Probl Cardiol 2007; 32(7): 375-410.
[http://dx.doi.org/10.1016/j.cpcardiol.2007.04.001] [PMID: 17560992]
[13]
Crean A, Khan SN, Davies LC, Coulden R, Dutka DP. Assessment of myocardial scar; Comparison between F-FDG PET, CMR and Tc-Sestamibi. Clin Med Cardiol 2009; 3(69): 76.
[http://dx.doi.org/10.4137/CMC.S730] [PMID: 20508767]
[14]
D’Egidio G, Nichol G, Williams KA, et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging 2009; 2(9): 1060-8.
[http://dx.doi.org/10.1016/j.jcmg.2009.02.017] [PMID: 19761983]
[15]
Anavekar NS, Chareonthaitawee P, Narula J, Gersh BJ. Revascularization in patients with severe left ventricular dysfunction: Is the assessment of viability still viable? J Am Coll Cardiol 2016; 67(24): 2874-87.
[http://dx.doi.org/10.1016/j.jacc.2016.03.571] [PMID: 27311527]
[16]
Choi JH, Chang SA, Choi JO, et al. Frequency of myocardial infarction and its relationship to angiographic collateral flow in territories supplied by chronically occluded coronary arteries Circulation 2013; 127(6): 703-9.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.112.092353] [PMID: 23277308]
[17]
Srivatsava MK, Indirani M, Sathyamurthy I, Sengottuvelu G, Jain AS, Shelley S. Role of PET-CT in the assessment of myocardial viability in patients with left ventricular dysfunction Indian Heart J 2016; 68(5): 693-9.
[http://dx.doi.org/10.1016/j.ihj.2015.11.017] [PMID: 27773409]
[18]
Beanlands RS, Ruddy TD, deKemp RA, et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol 2002; 40(10): 1735-43.
[http://dx.doi.org/10.1016/S0735-1097(02)02489-0] [PMID: 12446055]
[19]
Wang L, Lu MJ, Feng L, et al. Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion. J Nucl Cardiol 2018.
[http://dx.doi.org/10.1007/s12350-018-1241-8] [PMID: 29516366]
[20]
Zhang X, Liu XJ, Wu Q, et al. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET. J Nucl Med 2001; 42(8): 1166-73.
[PMID: 11483675]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 9
Year: 2019
Page: [884 - 889]
Pages: 6
DOI: 10.2174/1573405615666190701110620
Price: $58

Article Metrics

PDF: 15
HTML: 1